Skip to main content
Top
Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 1/2021

Open Access 01-12-2021 | Parkinson's Disease | Case Report

Unexplained worsening of parkinsonian symptoms in a patient with advanced Parkinson’s disease as the sole initial presentation of COVID-19 infection: a case report

Authors: Walaa A. Kamel, Ismail Ibrahim Ismail, Mohamed Ibrahim, Jasem Y. Al-Hashel

Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Issue 1/2021

Login to get access

Abstract

Background

Parkinson’s disease (PD) is a neurodegenerative condition that has been reported following viral infections in rare occasions. Several neurological complications have emerged in association with coronavirus disease 2019 (COVID-19), since its declaration as a pandemic. Herein, we present a novel case of unexplained worsening of PD as the sole initial presentation of COVID-19, in the absence of fever or respiratory symptoms.

Case presentation

A 56-year-old male with advanced PD presented with severe rigidity, dystonic posturing of both feet, and confusion of 4 days duration. His condition progressed to an akinetic-rigid state and confusion during the following week, and a routine nasopharyngeal swab tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the 9th day of onset. He developed fever and dyspnea later and was intubated on the 10th day.

Conclusion

To our knowledge, worsening of PD symptoms as the sole initial manifestation of SARS-CoV-2 infection, in the absence of other cardinal features of COVID-19, has not been reported in the literature. We suggest testing for COVID-19 infection in patients with PD, especially advanced cases, who present with unexplained worsening of symptoms, even in the absence of COVID-19 cardinal features.
Literature
2.
go back to reference Limphaibool N, Iwanowski P, Holstad MJV, Kobylarek D, Kozubski W. Infectious etiologies of parkinsonism: pathomechanisms and clinical implications. Front Neurol. 2019 Jun 19;10:652. doi: 10.3389/fneur.2019.00652. PMID: 31275235; PMCID: PMC6593078. Limphaibool N, Iwanowski P, Holstad MJV, Kobylarek D, Kozubski W. Infectious etiologies of parkinsonism: pathomechanisms and clinical implications. Front Neurol. 2019 Jun 19;10:652. doi: 10.3389/fneur.2019.00652. PMID: 31275235; PMCID: PMC6593078.
3.
go back to reference Conde G, Pájaro LD, Marzola ID, Villegas YR, Salazar LR. Neurotropism of SARS-CoV 2: mechanisms and manifestations. Journal of the neurological sciences. 2020 Apr;8. Conde G, Pájaro LD, Marzola ID, Villegas YR, Salazar LR. Neurotropism of SARS-CoV 2: mechanisms and manifestations. Journal of the neurological sciences. 2020 Apr;8.
4.
go back to reference Hu J, Jolkkonen J, Zhao C. Neurotropism of SARS-CoV-2 and its neuropathological alterations: similarities with other coronaviruses. Neuroscience & Biobehavioral Reviews. 2020 Oct;19. Hu J, Jolkkonen J, Zhao C. Neurotropism of SARS-CoV-2 and its neuropathological alterations: similarities with other coronaviruses. Neuroscience & Biobehavioral Reviews. 2020 Oct;19.
7.
go back to reference Méndez-Guerrero, Antonio et al “Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection.” Neurology 95.15 (2020): e2109-e2118. Web. 28 Dec. 2020. Méndez-Guerrero, Antonio et al “Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection.” Neurology 95.15 (2020): e2109-e2118. Web. 28 Dec. 2020.
9.
go back to reference Makhoul K, Jankovic J. Parkinson’s disease after COVID-19. Journal of the Neurological Sciences. 2021;15:422. Makhoul K, Jankovic J. Parkinson’s disease after COVID-19. Journal of the Neurological Sciences. 2021;15:422.
11.
go back to reference Zhai H, Lv Y, Xu Y, Wu Y, Zeng W, Wang T, Cao X, Xu Y. Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan. Journal of Neural Transmission.:1-2. Zhai H, Lv Y, Xu Y, Wu Y, Zeng W, Wang T, Cao X, Xu Y. Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan. Journal of Neural Transmission.:1-2.
13.
go back to reference Papa SM, Brundin P, Fung VS, Kang UJ, Burn DJ, Colosimo C, et al. MDS-Scientific Issues Committee. Impact of the COVID-19 pandemic on Parkinson’s disease and movement disorders. Mov Disord. 2020 Apr;6:6. Papa SM, Brundin P, Fung VS, Kang UJ, Burn DJ, Colosimo C, et al. MDS-Scientific Issues Committee. Impact of the COVID-19 pandemic on Parkinson’s disease and movement disorders. Mov Disord. 2020 Apr;6:6.
Metadata
Title
Unexplained worsening of parkinsonian symptoms in a patient with advanced Parkinson’s disease as the sole initial presentation of COVID-19 infection: a case report
Authors
Walaa A. Kamel
Ismail Ibrahim Ismail
Mohamed Ibrahim
Jasem Y. Al-Hashel
Publication date
01-12-2021
Publisher
Springer Berlin Heidelberg
DOI
https://doi.org/10.1186/s41983-021-00314-3

Other articles of this Issue 1/2021

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 1/2021 Go to the issue